Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Akiko Iwasaki and Shelli Farhadian.
Connection Strength

2.373
  1. Author Correction: Delayed production of neutralizing antibodies correlates with fatal COVID-19. Nat Med. 2021 Jul; 27(7):1309.
    View in: PubMed
    Score: 0.238
  2. Delayed production of neutralizing antibodies correlates with fatal COVID-19. Nat Med. 2021 07; 27(7):1178-1186.
    View in: PubMed
    Score: 0.236
  3. Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms. Cell Rep Med. 2021 05 18; 2(5):100288.
    View in: PubMed
    Score: 0.236
  4. Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface. Med (N Y). 2021 May 14; 2(5):591-610.e10.
    View in: PubMed
    Score: 0.236
  5. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med. 2021 03 01; 218(3).
    View in: PubMed
    Score: 0.233
  6. Detection of SARS-CoV-2 RNA by multiplex RT-qPCR. PLoS Biol. 2020 10; 18(10):e3000867.
    View in: PubMed
    Score: 0.227
  7. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020 12; 588(7837):315-320.
    View in: PubMed
    Score: 0.225
  8. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020 08; 584(7821):463-469.
    View in: PubMed
    Score: 0.224
  9. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021 07; 595(7866):283-288.
    View in: PubMed
    Score: 0.059
  10. Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva. Emerg Infect Dis. 2021 04; 27(4):1146-1150.
    View in: PubMed
    Score: 0.059
  11. Increased SARS-CoV-2 Testing Capacity with Pooled Saliva Samples. Emerg Infect Dis. 2021 04; 27(4).
    View in: PubMed
    Score: 0.059
  12. Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection. PLoS One. 2021; 16(3):e0243291.
    View in: PubMed
    Score: 0.059
  13. Tracking smell loss to identify healthcare workers with SARS-CoV-2 infection. PLoS One. 2021; 16(3):e0248025.
    View in: PubMed
    Score: 0.058
  14. SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity. Med (N Y). 2021 Mar 12; 2(3):263-280.e6.
    View in: PubMed
    Score: 0.058
  15. SARS-CoV-2 infection of the placenta. J Clin Invest. 2020 09 01; 130(9):4947-4953.
    View in: PubMed
    Score: 0.056
  16. Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2. N Engl J Med. 2020 09 24; 383(13):1283-1286.
    View in: PubMed
    Score: 0.056
  17. Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets. Nat Microbiol. 2020 10; 5(10):1299-1305.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.